|
1
|
Sipos JA and Mazzaferri EL: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol (R Coll Radiol).
22:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ
and Lee BJ: Clinical implication of the number of central lymph
node metastasis in papillary thyroid carcinoma: Preliminary report.
World J Surg. 34:2558–2563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roh JL, Park JY and Park CI: Total
thyroidectomy plus neck dissection in differentiated papillary
thyroid carcinoma patients: Pattern of nodal metastasis, morbidity,
recurrence, and postoperative levels of serum parathyroid hormone.
Ann Surg. 245:604–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murugan AK, Munirajan AK and Alzahrani AS:
Long noncoding RNAs: Emerging players in thyroid cancer
pathogenesis. Endocr Relat Cancer. 25:R59–R82. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Q, Chen J, Feng J and Wang J: Long
noncoding RNA PVT1 modulates thyroid cancer cell proliferation by
recruiting EZH2 and regulating thyroid-stimulating hormone receptor
(TSHR). Tumour Biol. 37:3105–3113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu H, Lv Z, An C, Shi M, Pan W, Zhou L,
Yang W and Yang M: Onco-lncRNA HOTAIR and its functional genetic
variants in papillary thyroid carcinoma. Sci Rep. 6:319692016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ribeiro FR, Meireles AM, Rocha AS and
Teixeira MR: Conventional and molecular cytogenetics of human
non-medullary thyroid carcinoma: Characterization of eight cell
line models and review of the literature on clinical samples. BMC
Cancer. 8:3712008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ugolini C, Borrelli N, Niccoli C, Elisei
R, Viola D, Vitti P, Miccoli P and Basolo F: Role of YAP-1 in
thyroid tumor progression and outcome. Appl Immunohistochem Mol
Morphol. 25:581–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao T, Wen D, Ma B, Hu JQ, Qu N, Shi RL,
Liu L, Guan Q, Li DS and Ji QH: Yes-associated protein 1 promotes
papillary thyroid cancer cell proliferation by activating the
ERK/MAPK signaling pathway. Oncotarget. 8:11719–11728. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Shen W, Li X, Zhang L and Jin X: The
lncRNA n340790 accelerates carcinogenesis of thyroid cancer by
regulating miR-1254. Am J Transl Res. 9:2181–2194. 2017.PubMed/NCBI
|
|
16
|
Li Z, Gao B, Hao S, Tian W, Chen Y, Wang
L, Zhang X and Luo D: Knockdown of lncRNA-PANDAR suppresses the
proliferation, cell cycle and promotes apoptosis in thyroid cancer
cells. EXCLI J. 16:354–362. 2017.PubMed/NCBI
|
|
17
|
Zhao JJ, Hao S, Wang LL, Hu CY, Zhang S,
Guo LJ, Zhang G, Gao B, Jiang Y, Tian WG and Luo DL: Long
non-coding RNA ANRIL promotes the invasion and metastasis of
thyroid cancer cells through TGF-β/Smad signaling pathway.
Oncotarget. 7:57903–57918. 2016.PubMed/NCBI
|
|
18
|
Liu K, Huang W, Yan DQ, Luo Q and Min X:
Overexpression of long intergenic noncoding RNA LINC00312 inhibits
the invasion and migration of thyroid cancer cells by
down-regulating microRNA-197-3p. Biosci Rep. 37(pii):
BSR201701092017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Celano M, Mignogna C, Rosignolo F,
Sponziello M, Iannone M, Lepore SM, Lombardo GE, Maggisano V,
Verrienti A, Bulotta S, et al: Expression of YAP1 in aggressive
thyroid cancer. Endocrine. 59:209–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Zeng W, Wang S, Zhao X, Guo Y, Yu
P, Yin X, Liu C and Huang T: A potential role for the Hippo pathway
protein, YAP, in controlling proliferation, cell cycle progression,
and autophagy in BCPAP and KI thyroid papillary carcinoma cells. Am
J Transl Res. 9:3212–3223. 2017.PubMed/NCBI
|
